Livtyle 70 Tablet contains Silymarin 70 mg, a hepatoprotective medicine derived from milk thistle that is widely used to support liver health and maintain normal liver function. It helps protect liver cells from damage caused by toxins, oxidative stress, and various liver-related conditions. The formulation is commonly prescribed as supportive therapy in individuals requiring liver protection and long-term liver care management.
Silymarin possesses antioxidant, anti-inflammatory, and cell-protective properties that help stabilize liver cell membranes and support the natural regeneration of liver tissue. By helping reduce oxidative damage within the liver, it contributes to maintaining healthy liver function and supports the body's ability to process and eliminate harmful substances. Its beneficial effects on liver health have led to widespread use in hepatology practice.
The tablet is frequently recommended as supportive therapy in conditions involving liver stress, fatty liver disease, alcohol-related liver damage, drug-induced liver injury, hepatitis, and other liver disorders as advised by healthcare professionals. Regular use under medical supervision may help improve overall liver wellness and support recovery in individuals with compromised liver function. The formulation is valued for its established role in comprehensive liver care programs.
With increasing awareness of liver health and the growing prevalence of lifestyle-related liver disorders, Livtyle 70 Tablet enjoys consistent demand in the hepatology segment. Its trusted composition, broad clinical acceptance, and relevance in long-term liver support make it a valuable product for retailers and distributors. The product offers excellent business potential and sustainable growth opportunities within the liver care and wellness market.